195 related articles for article (PubMed ID: 27371991)
1. Tumor dose-volume response in image-guided adaptive brachytherapy for cervical cancer: A meta-regression analysis.
Mazeron R; Castelnau-Marchand P; Escande A; Rivin Del Campo E; Maroun P; Lefkopoulos D; Chargari C; Haie-Meder C
Brachytherapy; 2016; 15(5):537-42. PubMed ID: 27371991
[TBL] [Abstract][Full Text] [Related]
2. Dose-effect response in image-guided adaptive brachytherapy for cervical cancer: A systematic review and meta-regression analysis.
Tang X; Mu X; Zhao Z; Zhao H; Mao Z
Brachytherapy; 2020; 19(4):438-446. PubMed ID: 32265118
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
[TBL] [Abstract][Full Text] [Related]
4. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
5. Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose?
Mazeron R; Gouy S; Escande A; Dumas I; Rivin Del Campo E; Bentivegna E; Bacorro W; Lefkopoulos D; Deutsch E; Morice P; Haie-Meder C; Chargari C
Brachytherapy; 2017; 16(4):862-869. PubMed ID: 28551312
[TBL] [Abstract][Full Text] [Related]
6. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
7. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
8. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
9. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy.
Dimopoulos JC; Pötter R; Lang S; Fidarova E; Georg P; Dörr W; Kirisits C
Radiother Oncol; 2009 Nov; 93(2):311-5. PubMed ID: 19679365
[TBL] [Abstract][Full Text] [Related]
10. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
11. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters.
Chargari C; Mazeron R; Escande A; Maroun P; Dumas I; Martinetti F; Tafo-Guemnie A; Deutsch E; Morice P; Haie-Meder C
Brachytherapy; 2016; 15(4):456-462. PubMed ID: 27180129
[TBL] [Abstract][Full Text] [Related]
12. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
[TBL] [Abstract][Full Text] [Related]
13. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
15. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
Iwai Y; Nemoto MW; Horikoshi T; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Uno T
Jpn J Radiol; 2020 Sep; 38(9):899-905. PubMed ID: 32333219
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
[TBL] [Abstract][Full Text] [Related]
18. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.
Kusada T; Toita T; Ariga T; Maemoto H; Hashimoto S; Shiina H; Kakinohana Y; Heianna J; Nagai Y; Kudaka W; Aoki Y; Murayama S
J Radiat Res; 2018 Jan; 59(1):67-76. PubMed ID: 29186565
[TBL] [Abstract][Full Text] [Related]
20. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
